Safety approval VP-001, page-4

The dosages are 3ug, 10ug then 30ug for the final cohort.
The final dosage for cohort 1 was on 14 August so we are now (as of Monday) 4 weeks post that event. I guess the Safety Review is no doubt underway as we speak. I don't know what is involved and how long it takes - maybe someone can assist with that knowledge. But, hopefully a short process and cohort 2 can commence within a week or two. No doubt we will be updated on 27 Sept at the conference call. But I'm very keen to hear some feedback on the discussions with big/other pharma re deals, mergers, licenses, buyouts etc. This is what will move the share price.